Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 20.95 USD -1.74% Market Closed
Market Cap: 13.3B USD

Intrinsic Value

The intrinsic value of one GMAB stock under the Base Case scenario is 36.67 USD. Compared to the current market price of 20.95 USD, Genmab A/S is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GMAB Intrinsic Value
36.67 USD
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Genmab A/S

Valuation History Unavailable

Historical valuation for GMAB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Genmab A/S
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genmab A/S

Current Assets 4B
Cash & Short-Term Investments 3.2B
Receivables 799m
Other Current Assets 12m
Non-Current Assets 2.5B
Long-Term Investments 30m
PP&E 271m
Intangibles 2.1B
Other Non-Current Assets 137m
Efficiency

Free Cash Flow Analysis
Genmab A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Genmab A/S

Revenue
7.9B DKK
Cost of Revenue
-324m DKK
Gross Profit
7.6B DKK
Operating Expenses
-5.1B DKK
Operating Income
2.5B DKK
Other Expenses
-97m DKK
Net Income
2.4B DKK
Fundamental Scores

GMAB Profitability Score
Profitability Due Diligence

Genmab A/S's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative Free Cash Flow
Exceptional Revenue Growth Forecast
Positive Gross Profit
72/100
Profitability
Score

Genmab A/S's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

GMAB Solvency Score
Solvency Due Diligence

Genmab A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Genmab A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 117.17 USD with a low forecast of 15.34 USD and a high forecast of 265.22 USD.

Lowest
Price Target
15.34 USD
27% Downside
Average
Price Target
117.17 USD
459% Upside
Highest
Price Target
265.22 USD
1 166% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Genmab A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for GMAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

GMAB News

What is the Intrinsic Value of one GMAB stock?

The intrinsic value of one GMAB stock under the Base Case scenario is 36.67 USD.

Is GMAB stock undervalued or overvalued?

Compared to the current market price of 20.95 USD, Genmab A/S is Undervalued by 43%.

Back to Top